GLP-1 is a hormone that has multiple actions on blood sugar, mediated by the GLP-1 receptors
Dose Adjustment : If fatigue is severe or persistent, healthcare providers may consider slowing the dose-escalation schedule (FDA labeling allows for flexible titration with 2.5 mg increments no more frequently than every 4 weeks) or maintaining a lower maintenance dose that balances therapeutic benefit with tolerability
Good hydration and close monitoring help reduce this risk
Antioxidant Power: Supports cell health, detoxification processes and the immune system
By the three-month mark, participants in the same study had lost about 9.6% of their body weight
So prescribing these purportedly "custom" compounded injections is "a practice that is worrisome, and it's worrisome because it positions compounding in a way that it was not intended to be, and I believe, frankly, that it pokes the bear." The bear here is large pharmaceutical companies